Compare CVS Health Corp (CVS) vs Shopify Inc. (SHOP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Shopify Inc. — how do they compare? CVS Health Corp trades at $86.85 (market cap $112.49B), while Shopify Inc. trades at $165.16 (market cap $213.62B). The key difference: Shopify Inc. is the larger of the two by market cap, and CVS Health Corp pays a 3.02% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Shopify Inc. for 78 Days on average.
| CVS | SHOP | |
|---|---|---|
Market Cap | $112.49B | $213.62B |
Volume | 8,467,392 | 6,320,766 |
Sector | Health | Technology |
52-Week High | $110.60 | $179.01 |
52-Week Low | $70.08 | $95.40 |
Typical Hold Time | 83 Days | 78 Days |
Enterprise Value | $174.83B | $208.85B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
SHOP trades at $164.54, up 0.03% with a bullish technical outlook supported by moving averages. The company shows strong revenue growth from $5.6B in 2022 to $11.56B in 2025, though valuation ratios remain elevated with a P/E of 112. Recent news highlights Shopify's AI innovations including Canvas for store building and open access for AI agents, contrasting with Amazon's restrictive approach.
Outlook remains positive with 67% analyst buy ratings and $168.37 consensus target. Key opportunities include AI-driven commerce tools and global expansion, while risks involve high valuation multiples and intense e-commerce competition. Earnings momentum is solid with two recent beats, though Q3 2026 results will be crucial for sustaining investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
